PEDIATRIA |
|
S.G. Gorbunov, T.A. Kovtun
Principles of diet therapy for pediatric patients with acute intestinal infections
|
8-13 |
|
|
S.S. Belous, B.A. Nanaeva
The place of various topical forms of mesalazine in the treatment of ulcerative colitis
|
14-20 |
|
T.L. Pilat, L.P. Kuzmina, L.M. Bezrukavnikova
Multicenter assessment of the effectiveness of nutritional detoxification process
|
22-31 |
|
E.I. Bugaeva, K.V. Zhmerenetsky, S.V. Dyachenko
On certain problems of diagnosis, treatment and prospects for the rehabilitation of patients with circulatory diseases after coronavirus infection COVID-19 (literature review)
|
32-38 |
|
D.I. Trukhan, A.F. Sulimov, L.Yu. Trukhan
Association of arterial hypertension and periodontal disease: a review of new data
|
40-51 |
|
N.V. Izmozherova, A.A. Popov, I.P. Antropova, L.I. Kadnikov, A.O. Polyanok, V.E. Ispavsky
Characterization of the plasminogen activator inhibitor type 1 gene (PAI-1) and its role in the development of arterial thrombosis
|
53-60 |
|
G.A. Ignatenko, G.G. Taradin, L.V. Kononenko
Cardiac myosin inhibitors in the treatment of hypertrophic cardiomyopathy (literature review)
|
62-69 |
|
V.V. Salukhov, B.V. Sagun
Key aspects of cardiovascular damage in COVID-19
|
70-78 |
|
M.V. Leonova
A new approach to influencing the renin-angiotensin-aldosterone system: aldosterone synthase inhibitor badrostat
|
80-83 |
|
D.S. Markhulia, K.A. Popugaev, S.S. Petrikov, I.M. Kuzmina, G.A. Ghazaryan, K.V. Kiselev, D.A. Kosolapov, E.V. Klychnikova, M.A. Godkov, M.V. Parkhomenko, A.I. Kramarenko, S.A. Golovanev, K.B. Mirzaev, D.A. Sychev
The influence of genetic resistance to antiplatelet agents on clinical and laboratory parameters and outcomes in ST-segment elevation myocardial infarction
|
84-94 |
|
B.G. Iskenderov, T.V. Lokhina, N.V. Berenshtein
Significance of vascular remodeling and vagosympathetic tone in the implementation of the antihypertensive effect of indapamide retard
|
96-103 |
|
A.I. Tarzimanova
Modern treatment options for arrhythmias: focus on propafenone
|
104-108 |
|
N.M. Vorobyeva, O.N. Tkacheva
Treatment and secondary prevention of venous thromboembolic complications: positions of apixaban
|
110-114 |
|
L.V. Vasilyeva, E.V. Gosteva, E.Yu. Suslova, L.R. Elzhurkaeva, M.A. Zolotareva
Pathogenetic mechanisms of the association of MMP-9 and TIMP-1 biomarkers with the severity of chronic obstructive pulmonary disease
|
116-121 |
|
V.O. Ponomarev, V.V. Omelyanovsky
Study of the pharmacodynamics of technology for treating resistant bacterial infections using quantum dots
|
122-127 |
|
E.K. Rumyantsev, N.M. Krasnova, V.M. Nikolaev, E.S. Prokopiev, M.P. Kirillina, D.A. Sychev
Lipid peroxidation in the body of patients with tuberculosis
|
128-132 |
|
Yu.G. Belotserkovskaya, A.G. Romanovskikh, I.P. Smirnov
Problems of managing patients with COPD in the post-pandemic waves of COVID-19
|
134-144 |
|
N.L. Ryabkova, I.M. Marusenko, N.D. Silvestrova, Ya.A. Avdeeva, V.A. Ryabkov
Comorbid infections in patients with rheumatic diseases in the Republic of Karelia: a retrospective analysis (according to the data from Republican Hospital n.a. V.A. Baranov, Petrozavodsk)
|
145-150 |
|
G.N. Levitsky, A.B. Berdalin, E.A. Kovrazhkina, A.G. Sanadze, V.V. Shestachenko, O.V. Vidergoldt
Concealment and denial of diagnosis in amyotrophic lateral sclerosis
|
151-158 |
|
T.L. Vizilo
Efficacy and safety of the Actitropil in the treatment of reactive asthenia in young patients
|
159-166 |
|
R.V. Shiroky, A.R. Zakaryaeva, D.M. Murtazalieva, M.A. Zolotov, N.G. Kvitivadze, M.Yu. Yakovlev, I.P. Parfenov, V.S. Fomin
Delirium in the intensive care unit: current state of the problem
|
167-172 |
|
I.I. Kuzmin, O.Yu. Kravtsova, A.I. Platova, I.I. Miroshnichenko
Benzodiazepines: classification, properties, quantification and monitoring
|
174-180 |
|
V.V. Osipova, Yu.V. Vorobiev, A.R. Artemenko, K.V. Skorobogatikh
Clinical aspects of the use of Anti-CGRP monoclonal antibodies in the prevention of migraine: a description of a clinical case
|
182-190 |
|
E.F. Gaisina, E.A. Basova, M.A. Frolova, A.S. Goskov
Countermeasures to the use of narcotic analgesics as pharmacological doping by athletes
|
192-196 |
DERMATOLOGY / ALLERGOLOGY |
|
E.V. Svechnikova, S.E. Zhufina
Modern ideas about the pathogenesis of chronic urticaria. Effective treatments
|
198-202 |
|
A.A. Martynov, A.V. Vlasova
Problems of medicine provision in dermatovenerology at the present stage
|
204-207 |
UROLOGY / NEPHROLOGY |
|
V.V. Danilov, I.Yu. Volnykh, V.V. Danilov, V.V. Danilov
Correction of urinary disorders in the early postoperative period after a trocar synthetic sling
|
208-212 |
|
|
E.A. Koltsova, E.A. Petrova, A.D. Kudryavtseva
Acquired androgen deficiency as a predictor of metabolic syndrome and ischemic stroke in men
|
214-219 |
Русский
